| Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level : a modelling study | Lancet |  | | 2026 | 5 | 26 |
|
| Estimating the Transmission Potential of Symptomatic and Asymptomatic Cholera Cases From Household Microbiological and Clinical Data | The Journal of infectious diseases |  | | 2026 | 3 | 4 |
|
| Evolving infectious disease dynamics shape school-based intervention effectiveness | Nature communications |  | | 2025 | 17 | 103 |
|
| Diagnostic performance and kinetics of hepatitis E viral RNA and IgM antibody test positivity in a genotype 1 outbreak in South Sudan | The Journal of infectious diseases |  | | 2025 | 15 | 70 |
|
| Rethinking cholera diagnostic test performance, interpretation, and evaluation : a field-based latent-class analysis in Bangladesh | The Lancet Microbe |  | | 2025 | 15 | 217 |
|
| Well-Being of Children and Adolescents with and without Special Health Care Needs Following the Lifting of Pandemic-Related Restrictions | The journal of pediatrics |  | | 2025 | 6 | 8 |
|
| The interplay of social and family environments in shaping adolescent health behaviours : a population-based study | Public health |  | | 2025 | 4 | 0 |
|
| Prevalence and factors associated with severe fatigue 2 years into the COVID-19 pandemic : a cross-sectional population-based study in Geneva, Switzerland | BMJ open |  | | 2025 | 111 | 294 |
|
| Covid-19 pandemic-related changes in teleworking, emotional exhaustion, and occupational burnout : a cross-sectional analysis of a cohort study | BMC public health |  | | 2025 | 89 | 520 |
|
| Association between SARS-CoV-2 infection and anti-apolipoprotein A-1 antibody in children | Frontiers in immunology |  | | 2025 | 62 | 130 |
|
| Acne-Related Quality of Life and Mental Health Among Adolescents : A Cross-Sectional Analysis | Clinical and experimental dermatology |  | | 2024 | 106 | 655 |
|
| Biopsychosocial risk factors for subjective cognitive decline among older adults during the COVID-19 pandemic : a population-based study | Public health |  | | 2024 | 19 | 225 |
|
| Mental health trajectories among the general population and higher-risk groups following the COVID-19 pandemic in Switzerland, 2021-2023 | Journal of affective disorders |  | | 2024 | 14 | 152 |
|
| Clinical surveillance systems obscure the true cholera infection burden in an endemic region | Nature medicine |  | | 2024 | 2 | 5 |
|
| Future time perspectives and concerns among adolescents in 2022 | BMJ paediatrics open |  | | 2024 | 11 | 73 |
|
| Prevalence of and risk factors for suicidal ideation in adolescents during the COVID-19 pandemic : a cross-sectional study | Swiss medical weekly |  | | 2024 | 14 | 60 |
|
| Impact of the COVID-19 pandemic on children and adolescents: determinants and association with quality of life and mental health—a cross-sectional study | Child and adolescent psychiatry and mental health |  | | 2023 | 185 | 240 |
|
| Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020–2021) : a longitudinal study in Switzerland | International journal for equity in health |  | | 2023 | 135 | 190 |
|
| Socioeconomic conditions and children's mental health and quality of life during the COVID-19 pandemic : An intersectional analysis | SSM, population health |  | | 2023 | 165 | 147 |
|
| Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study | The Lancet regional health. Europe |  | | 2023 | 184 | 244 |
|
| Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study | Infection |  | | 2023 | 112 | 171 |
|
| Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection | Nature communications |  | | 2023 | 153 | 97 |
|
| Development of hybrid immunity during a period of high incidence of Omicron infections | International journal of epidemiology |  | | 2023 | 97 | 218 |
|
| Cholera | Lancet |  | | 2022 | 11 | 0 |
|
| Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study | Occupational and environmental medicine |  | | 2022 | 256 | 121 |
|
| Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland | BMJ open |  | | 2022 | 238 | 101 |
|
| Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemic | PloS one |  | | 2022 | 176 | 272 |
|
| Applying mixture model methods to SARS-CoV-2 serosurvey data from Geneva | Epidemics |  | | 2022 | 200 | 179 |
|
| Epidemiological, virological and serological investigation of a SARS-CoV-2 outbreak (Alpha variant) in a primary school: A prospective longitudinal study | PloS one |  | | 2022 | 375 | 151 |
|
| A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland | Lancet. Infectious diseases |  | | 2022 | 250 | 136 |
|
| COVID-19-related school disruptions and well-being of children and adolescents in Geneva | Journal of paediatrics and child health |  | | 2022 | 163 | 200 |
|
| Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021 | Euro surveillance |  | | 2021 | 268 | 229 |
|
| Insights into household transmission of SARS-CoV-2 from a population-based serological survey | Nature Communications |  | | 2021 | 445 | 304 |
|
| Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland | Nature Communications |  | | 2021 | 266 | 228 |
|
| Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional Study | Viruses |  | | 2021 | 283 | 133 |
|
| Household COVID-19 risk and in-person schooling | Science |  | | 2021 | 1 | 1 |
|
| Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak | The Lancet Infectious Diseases |  | | 2021 | 316 | 239 |
|
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study | Scandinavian journal of public health |  | | 2021 | 360 | 207 |
|
| Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data : a cohort study | The Lancet microbe |  | | 2021 | 1 | 0 |
|
| Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance | Clinical Microbiology and Infection |  | | 2021 | 307 | 362 |
|
| A public health strategy for SARS-CoV-2, grounded in science, should guide Swiss schools through the coming winter | Swiss medical weekly |  | | 2021 | 418 | 197 |
|
| Age-specific mortality and immunity patterns of SARS-CoV-2 | Nature |  | | 2021 | 1 | 0 |
|
| Risk of reinfection after seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A population-based propensity-score matched cohort study | Clinical Infectious Diseases |  | | 2021 | 511 | 366 |
|
| Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201 | Emerging infectious diseases |  | | 2021 | 1 | 0 |
|
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study | The Lancet |  | | 2020 | 789 | 14 |
|
| HIT-COVID, a global database tracking public health interventions to COVID-19 | Scientific data |  | | 2020 | 4 | 18 |
|
| Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland | International Journal of Public Health |  | | 2020 | 308 | 195 |
|
| Socioeconomically Disadvantaged Neighborhoods Face Increased Persistence of SARS-CoV-2 Clusters | Frontiers in Public Health |  | | 2020 | 306 | 128 |
|
| Hepatitis E should be considered a neglected tropical disease | PLoS neglected tropical diseases |  | | 2019 | 14 | 67 |
|
| The projected impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa : A modeling study | PLoS medicine |  | | 2019 | 3 | 34 |
|
| Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease | New England journal of medicine |  | | 2016 | 4 | 8 |
|